Results for 'Cancer'
Increasing Clinical Trial Access for Blood Cancers
Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinkin…
Jun 7th • 19 mins listen
Transforming the Lung Cancer Treatment Landscape
Drs. Vamsi Velcheti and Nathan Pennell discuss novel approaches and key studies in lung cancer that were showcased at the 2024 ASCO Annual Meeting, including the Plenary abstracts LAURA and ADRIATIC.
Jun 21st • 34 mins listen
Addressing the Impact of Prior Authorization on Access to Cancer Treatment
Drs. Nathan Pennell and Nancy Lin discuss emerging data on the growing problem of prior authorization and insurance denials in cancer care, their potentially harmful impact on patient outcomes, and what can be done to fix the problem.
Jun 8th • 26 mins listen
Diversity in Cancer Clinical Trials
“I think it’s important to ensure that you consider each person uniquely. Because no matter how much I know or the nurse knows about the population, everybody is a little bit different. It’s really important to personalize every approach and ask them what they know and meet them …
May 29th • 27 mins listen
How Biosimilars Could Impact the Future of Cancer Care
Rowena Schwartz, PharmD, BCOP, associate professor of pharmacy at the University of Cincinnati, joins Deborah Struth, MSN, RN, ONS research associate, to discuss the rapid emergence of biosimilar products on the market and how they’ll impact the treatment of cancer. Learn more about what bio…
May 7th • 16 mins listen
How CAR and Other T Cells Are Revolutionizing Cancer Treatment
ONS member Cecily Snyder, BSN, RN, OCN®, BMTCN®, transplant case manager of the blood and marrow transplantation program at Nebraska Medicine in Omaha and member of the Metro Omaha ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss T-cell therapy…
Jan 24th • 27 mins listen
Monoclonal Antibodies to Treat Cancer and COVID-19
ONS member Donna Bydlon, BSN, RN, OCN®, network director of infusion services at St. Luke's University Hospital and Health Network in Bethlehem, PA, and member of the Greater Lehigh Valley ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss nursing co…
Jul 15th • 27 mins listen
Biomarker Testing Improves Outcomes for Patients With Non-Small Cell Lung Cancer
ONS member Beth Sandy, MSN, CRNP, thoracic oncology nurse practitioner at the University of Pennsylvania Abramson Cancer Center in Philadelphia, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss key considerations for oncology nurses regarding biomarker testing for …
May 24th • 34 mins listen
Learn How Nurse Practitioners Use Biomarker Testing in Cancer Care
ONS members Kristin Daly, MSN, ANP-BC, AOCNP®, medical oncology nurse practitioner at the Siteman Cancer Center at the Washington University School of Medicine in St. Louis, MO, and Jessica Pforr, RN, AOCNP®, nurse practitioner at Mon Medical Center in Morgantown, WV, join Stephanie Jardine,…
Mar 29th • 38 mins listen
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…
Mar 30th • 47 mins listen
IO Clinical Trials During COVID-19
On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …
Jun 23rd • 13 mins listen
Improving Community Clinical Trial Participation
Lack of community participation in cancer clinical trials has long been an issue, as has a lack of diversity among participants. On this CANCER BUZZ mini-podcast, learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioriti…
Oct 13th • 6 mins listen
Clinical Trial Access in Rural Areas
Clinical trials are crucial to cancer research and are often standard of care for patients with cancer, but for patients in rural areas, accessing clinical trials poses significant geographic and financial barriers. On this episode, we learn how Sanford Health harnessed its passion and creativity …
Oct 16th • 24 mins listen
Advancing Clinical Trial Equity
Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…
Jun 25th • 8 mins listen
Advanced Practitioners’ Role in Research
In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so. Hear how APs can leverage their deep role in the day-to-day cancer care decisions to improve diversit…
Jul 13th • 6 mins listen
Harnessing the Power of Registries to Understand the Impact of Treatment for Hodgkin Lymphoma on Fertility
Dr. Lindsay Morton of the National Cancer Institute at the National Institutes of Health reflects on research findings by Øvlisen et al that leverage large-scale linked registries in Denmark to suggest that improvements in both chemotherapy treatments and assisted reproductive technologies …
Aug 9th • 10 mins listen
New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity
Drs. Shaalan Beg and Travis Osterman discuss a machine learning model, recently featured in JCO Clinical Cancer Informatics, that uses electronic health record data to accurately predict the effectiveness and toxicity of treatment with immune checkpoint inhibitors. The new AI model can be use…
Mar 21st • 16 mins listen
The Use of Biosimilars in Oncology
Host Dr. John Sweetenham, associate director of Clinical Affairs at the UT Southwestern Harold C. Simmons Comprehensive Cancer Center, and Dr. Zeina Nahleh, breast cancer medical oncologist and regional chair of the Cleveland Clinic Florida Cancer Institute, discuss the new ASCO Expert Panel …
Mar 24th • 18 mins listen
Top ASCO24 Abstracts That Could Revolutionize Oncology
Drs. John Sweetenham and Angela DeMichele discuss potentially ground-breaking abstracts in breast and lung cancer as well as notable research on artificial intelligence and its impact on cancer care, all of which were featured at the 2024 ASCO Annual Meeting.
Jun 26th • 28 mins listen
Recent Advances and Future Directions in Oncology
Listen on Everand Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in acute myeloid leukemia, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung c…
Nov 23rd • 364 mins listen